Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer

Overview of attention for article published in BMC Cancer, August 2016

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 3,220 followers.

RT @AlexDobrovic: Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR p... https:/…

Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR p... https://t.co/3QbZknqgkz

RT @LaoSaal: Read our latest #TNBC #breastcancer pub: Synergistic PI3K/EGFR therapy in vitro & in vivo https://t.co/2Vr9TxiO2r https://t.co…

RT @LaoSaal: Read our latest #TNBC #breastcancer pub: Synergistic PI3K/EGFR therapy in vitro & in vivo https://t.co/2Vr9TxiO2r https://t.co…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.